45 computer-security-"https:"-"https:"-"https:" research jobs at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
interdisciplinary research and teaching at the intersection of the humanities and computational methods. The successful candidate will join the Computational Humanities research group, a vibrant and collaborative
-
and disease and apply this knowledge to the development of new and innovative clinical practise, alongside providing a rigorous academic programme for students. About the role Dr Seaborne’s group
-
United Kingdom Application Deadline 2 Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
12 Nov 2025 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Biological sciences Computer science Mathematics Researcher Profile Recognised Researcher (R2) Established
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, John Hopkins
-
the ability to translate between clinical and technical language while working with radiology informatics teams. A solid understanding of DICOM standards, PACS and RIS environments, GDPR, and image transfer
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, John Hopkins
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, and John
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, and John
-
project, an ambitious programme developing medical-grade nanoneedle bandages to deliver life-changing gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB). This is a unique